|Articles|February 1, 2017
- Pharmaceutical Executive-02-01-2017
- Volume 37
- Issue 2
Pharmaceutical Executive, February 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 9 years ago
Region in Reform? Access Pains and Gains in Latin Americaabout 9 years ago
CMED: The ‘Curupira’ of Brazil’s Pharma Marketover 9 years ago
The Trouble with Pharma Partnerships ... And How to Fix Themover 9 years ago
Reducing the Risk of Noncomplianceover 9 years ago
When You Need Experts, Use Themover 9 years ago
Pricing Pressures and Policy Changesover 9 years ago
Not Your Typical Pharma Datelineover 9 years ago
Market Access: Current and Future Statesover 9 years ago
Market Access: A UK Perspectiveover 9 years ago
Country Report: SingaporeAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5